Recombinant multi-species Alpha Sarcoglycan/SGCA protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine Alpha Sarcoglycan/SGCA protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a component of the dystrophin-glycoprotein complex (DGC), which is critical to the stability of muscle fiber membranes and to the linking of the actin cytoskeleton to the extracellular matrix. Its expression is thought to be restricted to striated muscle. Mutations in this gene result in type 2D autosomal recessive limb-girdle muscular dystrophy. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2008]
The Alternative Names of target: 50 kDa dystrophin-associated glycoprotein (50DAG),50DAG,ADL,Adhalin,Alpha Sarcoglycan,Alpha-SG,Alpha-sarcoglycan,Asg,DAG2,DMDA2,Dystroglycan-2,LGMD2D,LGMDR3,SCARMD1,SGCA,Sgca,adhalin

Target products collectionGo to Alpha Sarcoglycan/SGCA products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-T84584-Ag-1/ GM-Tg-hg-T84584-Ag-2 Human Alpha Sarcoglycan/SGCA protein Human
GM-Tg-rg-T84584-Ag-1/ GM-Tg-rg-T84584-Ag-2 Rat Alpha Sarcoglycan/SGCA protein Rat
GM-Tg-mg-T84584-Ag-1/ GM-Tg-mg-T84584-Ag-2 Mouse Alpha Sarcoglycan/SGCA protein Mouse
GM-Tg-cynog-T84584-Ag-1/ GM-Tg-cynog-T84584-Ag-2 Cynomolgus/Rhesus macaque Alpha Sarcoglycan/SGCA protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-T84584-Ag-1/ GM-Tg-felg-T84584-Ag-2 Feline Alpha Sarcoglycan/SGCA protein Feline
GM-Tg-cang-T84584-Ag-1/ GM-Tg-cang-T84584-Ag-2 Canine Alpha Sarcoglycan/SGCA protein Canine
GM-Tg-bovg-T84584-Ag-1/ GM-Tg-bovg-T84584-Ag-2 Bovine Alpha Sarcoglycan/SGCA protein Bovine
GM-Tg-equg-T84584-Ag-1/ GM-Tg-equg-T84584-Ag-2 Equine Alpha Sarcoglycan/SGCA protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-T84584-Ag-1/ GM-Tg-hg-T84584-Ag-2; GM-Tg-rg-T84584-Ag-1/ GM-Tg-rg-T84584-Ag-2;
GM-Tg-mg-T84584-Ag-1/ GM-Tg-mg-T84584-Ag-2; GM-Tg-cynog-T84584-Ag-1/ GM-Tg-cynog-T84584-Ag-2;
GM-Tg-felg-T84584-Ag-1/ GM-Tg-felg-T84584-Ag-2; GM-Tg-cang-T84584-Ag-1/ GM-Tg-cang-T84584-Ag-2;
GM-Tg-bovg-T84584-Ag-1/ GM-Tg-bovg-T84584-Ag-2; GM-Tg-equg-T84584-Ag-1/ GM-Tg-equg-T84584-Ag-2
Products Name Alpha Sarcoglycan/SGCA protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name Alpha Sarcoglycan/SGCA
Protein Sub-location Secreted Protein/Potential Cytokines
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine Alpha Sarcoglycan/SGCA protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.